Roswell Park Comprehensive Cancer Center researcher and faculty member Rodney Haring,PhD MSW , has been recognized with a 2017 Area/Regional Impact Award from the National Indian Health Board (NIHB).

BUFFALO, N.Y. — A treatment that works well for one cancer type can possibly make other cancers grow more quickly. That is the striking implication of new research from a team at Roswell Park Comprehensive Cancer Center, published in the journal Cell Reports.

Researchers at Roswell Park Comprehensive Cancer Center recently received more than $6.8 million in grant awards to support six specific projects aimed at improving supportive care and developing new immunotherapy and targeted therapy treatment approaches.

Roswell Park Cancer Institute has once again been named to Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, an annual list of centers that are national leaders in patient care, cancer outcomes and research.

BUFFALO, N.Y. — For many smokers fighting tobacco addiction, an encouraging voice on the other end of the phone is the difference-maker that helps them to quit smoking for good — often after a series of unsuccessful quit attempts.

An unprecedented network of centers collaborating to share information and translate these pooled resources into personalized treatments for cancer patients has expanded to 16 institutions with the addition of Roswell Park Comprehensive Cancer Center as a member.

New research led by a team from Roswell Park Comprehensive Cancer Center and published in the journal Nature Methods reports the development of genetically encoded GTP sensors that can rapidly detect changes in GTP levels in living cells.

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of cancer treatment that causes shooting or burning pain, numbness, tingling and cold sensitivity of the hands and feet for many cancer patients.